Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001)
NCT01833572
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Non-small-cell Lung Cancer
Interventions
DRUG:
Gefitinib
Sponsor
Fudan University